Liquidia Corp (LQDA)
12.46
-0.06
(-0.52%)
USD |
NASDAQ |
Apr 29, 16:00
12.60
+0.14
(+1.08%)
After-Hours: 05:02
Liquidia Total Liabilities (Quarterly): 71.04M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 71.04M |
| September 30, 2023 | 63.64M |
| June 30, 2023 | 60.94M |
| March 31, 2023 | 47.28M |
| December 31, 2022 | 38.78M |
| September 30, 2022 | 37.53M |
| June 30, 2022 | 36.98M |
| March 31, 2022 | 38.14M |
| December 31, 2021 | 28.46M |
| September 30, 2021 | 27.34M |
| June 30, 2021 | 25.36M |
| March 31, 2021 | 25.54M |
| December 31, 2020 | 28.45M |
| Date | Value |
|---|---|
| September 30, 2020 | 25.83M |
| June 30, 2020 | 26.56M |
| March 31, 2020 | 31.01M |
| December 31, 2019 | 33.89M |
| September 30, 2019 | 32.69M |
| June 30, 2019 | 32.62M |
| March 31, 2019 | 36.40M |
| December 31, 2018 | 30.73M |
| September 30, 2018 | 29.37M |
| June 30, 2018 | 33.70M |
| March 31, 2018 | 33.24M |
| December 31, 2017 | 48.54M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
25.36M
Minimum
Jun 2021
71.04M
Maximum
Dec 2023
37.48M
Average
32.69M
Median
Sep 2019
Total Liabilities (Quarterly) Benchmarks
| United Therapeutics Corp | 1.182B |
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 22.71M |
| Protalix BioTherapeutics Inc | 50.86M |
| Armata Pharmaceuticals Inc | 130.43M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 118.33M |
| Shareholders Equity (Quarterly) | 47.29M |
| Current Ratio | 4.846 |
| Net Debt Paydown Yield | 0.48% |